Literature DB >> 19048024

The natural history of trachoma infection and disease in a Gambian cohort with frequent follow-up.

Nicholas C Grassly1, Michael E Ward, Shirley Ferris, David C Mabey, Robin L Bailey.   

Abstract

BACKGROUND: The natural history of ocular Chlamydia trachomatis infections in endemic communities has not been well characterised and is an important determinant of the effectiveness of different mass treatment strategies to prevent blindness due to trachoma. METHODOLOGY/PRINCIPAL
FINDINGS: A multistate hidden Markov model was fitted to data on infection and active disease from 256 untreated villagers in The Gambia who were examined every 2 weeks over a 6-month period. Parameters defining the natural history of trachoma were estimated, and associations between these parameters, demographic and baseline immune measurements examined. The median incubation period following infection was estimated at 17 days (95% confidence interval: 11-28). Disease persisted for longer than infection (median 21 (15-32) weeks) versus 17 (12-24) weeks), with an estimated median duration of post-infection inflammation of 5 (3-8) weeks. The duration of active disease showed a significant decline with age even after accounting for lower rates of re-infection and disease at older ages (p = 0.004). Measurements of levels of baseline IgA to epitopes in the major outer membrane protein of Chlamydia trachomatis were not significantly correlated with protection or more rapid clearance of infection.
CONCLUSIONS: The average duration of infection with Chlamydia trachomatis especially at younger ages is long. This contributes to the persistence and gradual return of trachoma after community-wide treatment with antibiotics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19048024      PMCID: PMC2584235          DOI: 10.1371/journal.pntd.0000341

Source DB:  PubMed          Journal:  PLoS Negl Trop Dis        ISSN: 1935-2727


  37 in total

1.  PCR-detected Chlamydia trachomatis infections from the uterine cervix of young women from the general population: prevalence and risk determinants.

Authors:  C Munk; S A Morré; S K Kjaer; P A Poll; J E Bock; C J Meijer; A J van den Brule
Journal:  Sex Transm Dis       Date:  1999-07       Impact factor: 2.830

2.  Global elimination of trachoma: how frequently should we administer mass chemotherapy?

Authors:  T Lietman; T Porco; C Dawson; S Blower
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

3.  Inoculation of human volunteer with egg-grown inclusion conjunctivitis virus.

Authors:  P THYGESON; L HANNA; C DAWSON; J ZICHOSCH; E JAWETZ
Journal:  Am J Ophthalmol       Date:  1962-05       Impact factor: 5.258

4.  Multi-state models and diabetic retinopathy.

Authors:  G Marshall; R H Jones
Journal:  Stat Med       Date:  1995-09-30       Impact factor: 2.373

5.  A simple system for the assessment of trachoma and its complications.

Authors:  B Thylefors; C R Dawson; B R Jones; S K West; H R Taylor
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

6.  Mass treatment with single-dose azithromycin for trachoma.

Authors:  Anthony W Solomon; Martin J Holland; Neal D E Alexander; Patrick A Massae; Aura Aguirre; Angels Natividad-Sancho; Sandra Molina; Salesia Safari; John F Shao; Paul Courtright; Rosanna W Peeling; Sheila K West; Robin L Bailey; Allen Foster; David C W Mabey
Journal:  N Engl J Med       Date:  2004-11-04       Impact factor: 91.245

7.  Severe disease in children with trachoma is associated with persistent Chlamydia trachomatis infection.

Authors:  L D Bobo; N Novak; B Muñoz; Y H Hsieh; T C Quinn; S West
Journal:  J Infect Dis       Date:  1997-12       Impact factor: 5.226

8.  Global data on visual impairment in the year 2002.

Authors:  Serge Resnikoff; Donatella Pascolini; Daniel Etya'ale; Ivo Kocur; Ramachandra Pararajasegaram; Gopal P Pokharel; Silvio P Mariotti
Journal:  Bull World Health Organ       Date:  2004-12-14       Impact factor: 9.408

9.  The influence of local antichlamydial antibody on the acquisition and persistence of human ocular chlamydial infection: IgG antibodies are not protective.

Authors:  R L Bailey; M Kajbaf; H C Whittle; M E Ward; D C Mabey
Journal:  Epidemiol Infect       Date:  1993-10       Impact factor: 2.451

10.  Polymerase chain reaction for the detection of ocular chlamydial infection in trachoma-endemic communities.

Authors:  R L Bailey; T J Hampton; L J Hayes; M E Ward; H C Whittle; D C Mabey
Journal:  J Infect Dis       Date:  1994-09       Impact factor: 5.226

View more
  51 in total

Review 1.  Environmental sanitary interventions for preventing active trachoma.

Authors:  Mansur Rabiu; Mahmoud B Alhassan; Henry O D Ejere; Jennifer R Evans
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 2.  Application of Disease Etiology and Natural History to Prevention in Primary Health Care: A Discourse.

Authors:  Franklin White
Journal:  Med Princ Pract       Date:  2020-05-18       Impact factor: 1.927

3.  Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma.

Authors:  Jeremy D Keenan; Takele Lakew; Wondu Alemayehu; Muluken Melese; Travis C Porco; Elizabeth Yi; Jenafir I House; Zhaoxia Zhou; Kathryn J Ray; Nisha R Acharya; John P Whitcher; Bruce D Gaynor; Thomas M Lietman
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

4.  The epidemiological dynamics of infectious trachoma may facilitate elimination.

Authors:  Thomas M Lietman; Teshome Gebre; Berhan Ayele; Kathryn J Ray; M Cyrus Maher; Craig W See; Paul M Emerson; Travis C Porco
Journal:  Epidemics       Date:  2011-04-06       Impact factor: 4.396

5.  How reliable are tests for trachoma?--a latent class approach.

Authors:  Craig W See; Wondu Alemayehu; Muluken Melese; Zhaoxia Zhou; Travis C Porco; Stephen Shiboski; Bruce D Gaynor; John Eng; Jeremy D Keenan; Thomas M Lietman
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-03       Impact factor: 4.799

6.  A Longitudinal Analysis of Chlamydial Infection and Trachomatous Inflammation Following Mass Azithromycin Distribution.

Authors:  Daniel P Morberg; Wondu Alemayehu; Muluken Melese; Takele Lakew; Alemayehu Sisay; Zhaoxia Zhou; Vicky Cevallos; Catherine E Oldenburg; Travis C Porco; Thomas M Lietman; Jeremy D Keenan
Journal:  Ophthalmic Epidemiol       Date:  2018-08-28       Impact factor: 1.648

7.  Targeting antibiotics to households for trachoma control.

Authors:  Isobel M Blake; Matthew J Burton; Anthony W Solomon; Sheila K West; María-Gloria Basáñez; Manoj Gambhir; Robin L Bailey; David C W Mabey; Nicholas C Grassly
Journal:  PLoS Negl Trop Dis       Date:  2010-11-02

8.  Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities.

Authors:  Matthew J Burton; Martin J Holland; Pateh Makalo; Esther A N Aryee; Ansumana Sillah; Sandra Cohuet; Angels Natividad; Neal D E Alexander; David C W Mabey; Robin L Bailey
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

9.  The development of an age-structured model for trachoma transmission dynamics, pathogenesis and control.

Authors:  Manoj Gambhir; Maria-Gloria Basáñez; Matthew J Burton; Anthony W Solomon; Robin L Bailey; Martin J Holland; Isobel M Blake; Christl A Donnelly; Ibrahim Jabr; David C Mabey; Nicholas C Grassly
Journal:  PLoS Negl Trop Dis       Date:  2009-06-16

Review 10.  The global burden of trachoma: a review.

Authors:  Matthew J Burton; David C W Mabey
Journal:  PLoS Negl Trop Dis       Date:  2009-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.